Aug 8 (Reuters)-
Human Metabolome Technologies, Inc.
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Jun 30, 2025 Jun 30, 2024 Jun 30, 2026 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 1.46 1.35 1.60
(+8.1 pct) (+3.6 pct) (+10.0 pct)
Operating 249 mln 220 mln 300 mln
(+13.3 pct) (+4.4 pct) (+20.2 pct)
Recurring 240 mln 241 mln 300 mln
(-0.2 pct) (+3.8 pct) (+24.5 pct)
Net
Net 256 mln 243 mln 260 mln
(+5.4 pct) (-14.9 pct) (+1.4 pct)
EPS 43.67 yen 41.14 yen 45.68 yen
Ann Div 15.00 yen 15.00 yen 18.00 yen
-Q2 Div NIL NIL NIL
-Q4 Div 15.00 yen 15.00 yen 18.00 yen
NOTE - Human Metabolome Technologies, Inc..
*Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=6090.T